ConductScience.org, home

Cell line · CVCL_0327

Hepa 1-6

Cancer cell line, Mus musculus. Hepatocellular carcinoma of the mouse. 79 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. Hepa 1-6. Cell lines, record CVCL_0327. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0327

On this page

Cell line

As Cellosaurus gives it.

Name
Hepa 1-6
Accession
CVCL_0327
RRID
RRID:CVCL_0327
Synonyms
HEPA 1-6, Hepa-1-6, Hepa1-6
Species
Mus musculus (Mouse)
Sex
Female
Age at sampling
Age unspecified
Category
Cancer cell line
Diseases
Hepatocellular carcinoma of the mouse (NCIt C38756)
Derived from
Liver (in situ)
Parent
Hepa-1 (CVCL_S550)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers79

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
PubMed 43000531Nat Commun2026Its Methods give the RRID and name the linePubMed
Chronic stress activates a hypothalamic vagal circuit to promote hepatocellular carcinoma progression in male mice.Nat Commun2026Its Methods give the RRID and name the linePubMed
Liver-specific amino acid metabolism impacts on efficacy of cancer immunotherapy.Oncogene2026Its Methods give the RRID and name the linePubMed
Fedratinib treatment correlates with suppressed STAT3/AKT/calpain-1 signaling and inhibits hepatocellular carcinoma progression.Transl Gastroenterol Hepatol2026Its Methods give the RRID and name the linePubMed
XIAP inhibition augments personalized neoantigen vaccine-driven antitumor immunity in orthotopic hepatocellular carcinoma.J Immunother Cancer2026Its Methods give the RRID and name the linePubMed
Metabolic Reprogramming of NSUN2-Mediated m5C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity.Cancer Commun (Lond)2026Its Methods give the RRID and name the linePubMed
Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis.JHEP Rep2026Its Methods give the RRID and name the linePubMed
Mechanosensors Collaborate to Regulate DNA Damage Repair in Hepatocellular Carcinoma.Cancer Res2026Its Methods give the RRID and name the linePubMed
Targeting p21-High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.J Exp Med2026Its Methods give the RRID and name the linePubMed

1 to 10 of 79

See all 79 papers

Relatives35

RelationCell lineAccessionProblemSource
ParentHepa-1CVCL_S550Cell lines
Derived from itDt81Hepa1-6CVCL_IU28Cell lines
Derived from itEDITGENE Hepa1-6-Cas9CVCL_F5QVCell lines
Derived from itEDITGENE Hepa1-6-CopGFPCVCL_F6C5Cell lines
Derived from itEDITGENE Hepa1-6-FLUCCVCL_F5UNCell lines
Derived from itHepa 1-6-LucCVCL_C8Y7Cell lines
Derived from itHepa 1-6/10RCVCL_A5BHCell lines
Derived from itHepa/8F5CVCL_RI52Cell lines
Derived from itHepa1-6-Fluc-NeoCVCL_RA19Cell lines
Derived from itHepa1-6-Fluc-Neo/eGFP-PuroCVCL_RA20Cell lines

Cell banks13

Cell bankCatalog numberStatusSource
ATCCCRL-1830ATCC
AddexBioC0015005/4999Cellosaurus
BCRC60051BCRC
CCTCCGDC0313Cellosaurus
CLS400474CLS
DSMZACC-175DSMZ
ECACC92110305ECACC
EDITGENEEDC00250EDITGENE
HysigenTCM-C734Hysigen
IZSLERBS TCL 157Cellosaurus

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0327

GET https://conductscience.org/api/cell-lines/v1/CVCL_0327/papers?page=2